– USA, CA – Rockley Photonics Holdings Limited (NYSE: RKLY), a global medical technology company, today announced the appointment of Randy Meier to its board of directors as president and CEO, effective immediately, succeeding Dr. Andrew Rickman who takes on the role of executive chairman.
“I want to thank Andrew for the commitment and leadership he demonstrated during his nine years as CEO of Rockley. His insight and support will continue to be important to the success of the Company. I also want to thank Caroline for her contribution to the board,” said CEO, Randy Meier. “I look forward to advancing our strategic vision, focusing on our three key priorities, and positioning the company to capitalize on the opportunities ahead of us.”
The Company also announced that Dr. Caroline Brown is stepping down from the board.
About Rockley Photonics
Formed in 2013, Rockley is a global medical technology company focused on delivering leading-edge silicon photonics-based biosensing solutions that target a portfolio of biomarkers. Rockley’s ground-breaking end-to-end biosensing platform unlocks unique spectra-based biomarkers enabling insights into personal health and well-being. With next-generation biosensing platforms specifically designed for mobile health monitoring, Rockley is laying the foundation for a new generation of biomedical applications across multiple industries.
For more information: https://rockleyphotonics.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
